Literature DB >> 15067707

The effect of delta G on the transport and oral absorption of macromolecules.

Noha N Salama1, Alessio Fasano, Manjusha Thakar, Natalie D Eddington.   

Abstract

Delta G (DeltaG) is the biologically active fragment of Zonula Occludens Toxin (Zot), an absorption enhancer, that reversibly opens the tight junctions of epithelial and endothelial cells in the small intestine and brain. This study evaluates the possible use of DeltaG in enhancing the oral bioavailability of macromolecules using large paracellular markers as model agents. The transport of [(14)C]Inulin and [(14)C]PEG4000 was evaluated across Caco-2 cells with DeltaG (0, 100, 180 microg/ml). The apparent permeability coefficients (P(app)) were calculated. The in vitro toxicity of DeltaG (180 microg/ml) was assessed. Sprague Dawley rats were dosed intraduodenally (ID) with the following treatments: [(14)C]Inulin or [(14)C]PEG4000 (30 microci/kg) w/o DeltaG (720 microg/kg)/protease inhibitors (PI). Blood was collected and plasma was analyzed for radioactivity. DeltaG (180 microg/ml) increased [(14)C]Inulin and [(14)C]PEG4000 P(app) by 82.6 and 24.4%, respectively, without any toxicity. After ID administration with DeltaG/PI, C(max) and AUC were significantly (p < 0.05) increased for both Inulin and PEG4000. However, Inulin displayed greater enhancement ratios in vitro and in vivo. This study suggests that DeltaG may be used to enhance the oral bioavailability of macromolecules (e.g., proteins) after coadministration through modulation of paracellular transport. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:1310-1319, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067707     DOI: 10.1002/jps.20052

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Effect of rhamnolipids on permeability across Caco-2 cell monolayers.

Authors:  Charity J Wallace; Scott H Medina; Mohamed E H ElSayed
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

2.  Biomaterial-tight junction interaction and potential impacts.

Authors:  Xiangfei Han; Ershuai Zhang; Yuanjie Shi; Boyi Song; Hong Du; Zhiqiang Cao
Journal:  J Mater Chem B       Date:  2019-07-31       Impact factor: 6.331

Review 3.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

4.  Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.

Authors:  Nusrat A Motlekar; Alessio Fasano; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2006-06       Impact factor: 5.121

5.  Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.

Authors:  Nicholas A Peppas; Daniel A Carr
Journal:  Chem Eng Sci       Date:  2009-11-16       Impact factor: 4.311

6.  Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall.

Authors:  Alessio Fasano
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 7.  Accessory Toxins of Vibrio Pathogens and Their Role in Epithelial Disruption During Infection.

Authors:  Diliana Pérez-Reytor; Victor Jaña; Leonardo Pavez; Paola Navarrete; Katherine García
Journal:  Front Microbiol       Date:  2018-09-20       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.